Oct 18, 2017
Dr. Frédéric Triebel presenting at the World Immunotherapy Congress 2017
Oct 16, 2017
IMP321 New Data Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting
Sep 07, 2017
Prima Secures Japanese Patent Grant for IMP731 Antibody
Sep 05, 2017
Prima Secures Japanese Patent Grant for Lead Product IMP321 in Infectious Disease
Aug 29, 2017
Prima BioMed and Monash University Receive Funding Grant for LAG-3 Research Project
Aug 19, 2017
Prima BioMed Appoints Non-Executive Director to the Board
Aug 14, 2017
Prima BioMed Receives A$1.3 Million Tax Refund from French Government
Jul 18, 2017
Financial Update 2H17
Jul 15, 2017
Prima BioMed Announces Second Milestone Payment for IMP701 Program
Jul 08, 2017
Prima BioMed Announces Approval for the Initiation of the ‘INSIGHT’ Clinical Trial
Jun 28, 2017
Prima BioMed Announces Pricing of US$5.0 Million Registered Direct Offering of Its American Depositary Shares
Jun 25, 2017
Operational Update
